Fungal infections are a serious public health threat, affecting a wide variety of populations worldwide. This review presents the current state of knowledge on fungal infections, focusing on epidemiology, etiology, clinical manifestations, and emerging trends. Findings are based on 35 peer-reviewed studies and focus on both well-known and emerging fungal pathogens, diagnostic advances, and therapeutic challenges. In addition, this review emphasizes the role of environmental and social factors in shaping the dynamics of fungal disease and highlights the importance of a global, multidisciplinary effort to combat the rise in fungal disease. The literature for this review was collected from PubMed and Google Scholar using the key words “fungal infections” combined with “epidemiology”, “etiology”, “risk factors”, “symptoms”, “complications”, “treatment”, and “trends”.
Currently, antimicrobial-resistant bacteria and the global repercussions of this resistance are emerging as one of the most significant threats to public health. The global scope of the problem is discussed, with recent data showing that antimicrobial resistance (AMR) causes over a million fatalities annually, and projections suggest that this number will rise sharply by 2050. This review aims to provide a comprehensive analysis of this issue, focusing on the mechanisms of antibiotic resistance, its impact on public health and the economy, proposed strategies for addressing the problem, and potential alternative therapeutic approaches. This review is based on a thorough examination of current publications from the World Health Organization (WHO), European Centre for Disease Prevention and Control (ECDC), and relevant scientific literature obtained from databases such as PubMed. The primary objective of this publication is to highlight the escalating nature of this problem and to promote education and awareness in this critical area of healthcare.
Cannabis is one of the most widely used psychoactive substances globally. In several countries, including Canada, the Netherlands, certain U.S. states, and Australia, its possession is legal. With its growing popularity in recent years, the impact of cannabis on mental health has become a focal point of numerous scientific studies. The aim of this review was to summarize the current evidence-based knowledge on the impact of cannabis on mental health. This article explores the relationship between cannabis use and specific mental disorders. The reviewed literature was sourced from PubMed and Google Scholar using the keywords "mental health", "cannabis", "psychosis" "schizophrenia" "depression" and "cognitive functions".
6 March 2025 in Journal of Education, Health and Sport
Introduction and purpose Acute bacterial prostatitis (ABP) is a troublesome prostate infection that manifests with a range of irritative urinary symptoms, pelvic discomfort, potentially progressing to urinary retention. ABP can cause severe complications, including prostatic abscess and sepsis. Hence the need to collect and share current knowledge on risk factors, diagnosis and treatment. A brief description of the state of knowledge ABP is in most cases caused by E. Coli. Symptoms are non-specific and many patients lack identifiable risk factors. It is important to perform cautious digital rectal examination, urine analysis and culture when diagnosing acute bacterial prostatitis. Oral fluoroqinolones are the first-line outpatient treatment for non-complicated cases. Patients presenting symptoms indicative of urosepsis should be hospitalized and treated with intravenous antibiotics. Increasing antimicrobial resistance observed among Enterobacterales necessitates the search for new therapeutic agents. Lack of clinical improvement after initial treatment may indicate resistant pathogens or the development of prostatic abscess (PA). PA can be diagnosed with transrectal ultrasound and may require surgical intervention. Without proper treatment ABP can transform to chronic bacterial prostatitis. Transrectal prostate biopsy is associated with higher risk of ABP therefore antibiotical prophylaxis should be used. Conclusions ABP is not the most common type of prostatitis, but it should not be overlooked. Better knowledge about risks associated with ABP and available treatment leads to more accurate therapy choices. Awareness of the challenges posed by antibiotic resistance leads to the development of new, more effective treatments.
Low back pain (LBP) is a common condition affecting many individuals worldwide. Furthermore, it represents a significant economic challenge for healthcare systems due to its substantial associated costs. The etiology of LBP is complex but, in most cases, is not caused by serious underlying diseases. Physical examination remains the cornerstone of diagnosis, while additional tests, including imaging, are determined based on the clinical context. Treatment involves a combination of non-pharmacological, pharmacological, and invasive interventions. Despite numerous attempts to prevent LBP, only a few methods have been scientifically proven to be effective. The aim of this review was to provide a comprehensive summary of evidence-based information and approaches regarding the pathogenesis, treatment, and prevention of LBP. The literature reviewed was sourced from PubMed and Google Scholar Rusing the key words "low back pain" combined with terms such as "pathogenesis," "diagnostics," "imaging diagnostics," "treatment," and "prevention."
Bone cancers in children are uncommon, making up approximately 5,5 % of all pediatric cancers. Childhood cancers are characterized by rapid development, and any delay in diagnosis can lead to serious consequences and even be life-threatening. The most common malignant tumors in key practice are: osteosarcoma (OS) and Ewing sarcoma (EWS). OS and EWS in children and adolescents require integrated diagnostics and age-appropriate therapy to ensure the best possible treatment outcomes. In recent years, the survival rates of pediatric cancer patients have improved and, consequently, it is necessary to reduce the long-term, late effects of treatment in order to promote the reduction of the deterioration in quality of life caused by treatment and to ensure the best possible return to everyday life.